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atherosclerosis assessed by coronary calcium,
1547
Prevalence and severity of coronary artery
calcification on coronary artery computed
tomography in black and white subjects, 39
Prevalence of coronary artery calcium among
diabetic individuals without known coronary
artery disease, 1008
Calcium channel blockers
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and AT-1 receptors in hypertension due to
endogenous angiotensin II, 666
Cardiac muscle
Skeletal muscle meets cardiac muscle (editorial),
1084
Cardiac output
Limitation of cardiac output by total isovolumic
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support as a bridge to cardiac transplantation,
381
Why is chronic kidney disease the “spoiler” for
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Avoidance of the left lateral decubitus position
during sleep in patients with heart failure:
relationships to cardiac size and function, 227
Left ventricle
Diastolic mitral annular velocity during the
development of heart failure, 1590
Echocardiographic characteristics of professional
football players, 280
Exercise training improves biventricular oxidative
metabolism and left ventricular efficiency in
patients with dilated cardiomyopathy, 460
Influence of systolic blood pressure and body mass
index on left ventricular structure in healthy
African-American and white young adults:
the CARDIA study, 955
Left ventricular septal and apex pacing for optimal
pump function in canine hearts, 1218
Left ventricular structural and function
characteristics in Cushing’s syndrome, 2275
Magnetic resonance imaging of targeted catheter-
based implantation of myogenic precursor
cells into infarcted left ventricular
myocardium, 1841
Right versus left ventricular shock (editorial), 1280
Robotically assisted left ventricular epicardial lead
implantation for biventricular pacing, 1414
Symptoms and left ventricular size and function in
patients with chronic aortic regurgitation
(editorial), 1325
Left ventricular apical ballooning
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